Indomethacin enhancement of spleen‐cell responsiveness to mitogen stimulation in tumorous mice

Louis M. Pelus, Helen R. Strausser

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Spleen cells removed from C57Bl/6J mice bearing a methylcholanthrene‐induced fibrosarcoma (MC‐16) demonstrate suppressed responsiveness to phytohemagglutinin (PHA) and bacterial lipopolysaccharide (LPS) induced mitogenesis as compared to non‐tumorous mice. A similar depression of PHA‐induced mitogenesis was observed with spleen cells from C3H/HeJ mice bearing syngeneic mammary adenocarcinomas (C3HBA). The administration of indomethacin, a non‐competitive irreversible prostaglandin (Pg) synthesis inhibitor, (75 or 100 μg/mouse, IP) on an alternate day basis to groups of tumor‐bearing mice of both strains, significantly enhanced immune cell responsiveness to mitogenic stimulation. The addition of indomethacin (10 μg/ml) to cultures of spleen cells from these tumor‐bearing mice, as well as to DBA/1J mice bearing the Cloudman S‐91 melanoma, enhanced spleen‐cell responsiveness to mitogen‐induced DNA synthesis by as much as 156%. Indomethacin administration in vivo or in vitro had no significant effect on mitogen‐induced DNA synthesis of spleen cells from non‐tumor‐bearing animals. It is hypothesized that tumors, or tumor‐cell antigens, increase Pg production of a population of spleen cells, and that the increased Pg content of the spleen may be important in controlling immune responsiveness in mice.

Original languageEnglish (US)
Pages (from-to)653-660
Number of pages8
JournalInternational Journal of Cancer
Volume18
Issue number5
DOIs
StatePublished - Nov 15 1976

Fingerprint

Mitogens
Indomethacin
Spleen
Prostaglandins
Prostaglandin Antagonists
Inbred DBA Mouse
Experimental Melanomas
Inbred C3H Mouse
Fibrosarcoma
DNA
Phytohemagglutinins
Lipopolysaccharides
Adenocarcinoma
Breast
Cell Culture Techniques
Antigens
Population
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Indomethacin enhancement of spleen‐cell responsiveness to mitogen stimulation in tumorous mice. / Pelus, Louis M.; Strausser, Helen R.

In: International Journal of Cancer, Vol. 18, No. 5, 15.11.1976, p. 653-660.

Research output: Contribution to journalArticle

@article{c35f0da13b9042a38890b7bf0ef4f1f2,
title = "Indomethacin enhancement of spleen‐cell responsiveness to mitogen stimulation in tumorous mice",
abstract = "Spleen cells removed from C57Bl/6J mice bearing a methylcholanthrene‐induced fibrosarcoma (MC‐16) demonstrate suppressed responsiveness to phytohemagglutinin (PHA) and bacterial lipopolysaccharide (LPS) induced mitogenesis as compared to non‐tumorous mice. A similar depression of PHA‐induced mitogenesis was observed with spleen cells from C3H/HeJ mice bearing syngeneic mammary adenocarcinomas (C3HBA). The administration of indomethacin, a non‐competitive irreversible prostaglandin (Pg) synthesis inhibitor, (75 or 100 μg/mouse, IP) on an alternate day basis to groups of tumor‐bearing mice of both strains, significantly enhanced immune cell responsiveness to mitogenic stimulation. The addition of indomethacin (10 μg/ml) to cultures of spleen cells from these tumor‐bearing mice, as well as to DBA/1J mice bearing the Cloudman S‐91 melanoma, enhanced spleen‐cell responsiveness to mitogen‐induced DNA synthesis by as much as 156{\%}. Indomethacin administration in vivo or in vitro had no significant effect on mitogen‐induced DNA synthesis of spleen cells from non‐tumor‐bearing animals. It is hypothesized that tumors, or tumor‐cell antigens, increase Pg production of a population of spleen cells, and that the increased Pg content of the spleen may be important in controlling immune responsiveness in mice.",
author = "Pelus, {Louis M.} and Strausser, {Helen R.}",
year = "1976",
month = "11",
day = "15",
doi = "10.1002/ijc.2910180514",
language = "English (US)",
volume = "18",
pages = "653--660",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Indomethacin enhancement of spleen‐cell responsiveness to mitogen stimulation in tumorous mice

AU - Pelus, Louis M.

AU - Strausser, Helen R.

PY - 1976/11/15

Y1 - 1976/11/15

N2 - Spleen cells removed from C57Bl/6J mice bearing a methylcholanthrene‐induced fibrosarcoma (MC‐16) demonstrate suppressed responsiveness to phytohemagglutinin (PHA) and bacterial lipopolysaccharide (LPS) induced mitogenesis as compared to non‐tumorous mice. A similar depression of PHA‐induced mitogenesis was observed with spleen cells from C3H/HeJ mice bearing syngeneic mammary adenocarcinomas (C3HBA). The administration of indomethacin, a non‐competitive irreversible prostaglandin (Pg) synthesis inhibitor, (75 or 100 μg/mouse, IP) on an alternate day basis to groups of tumor‐bearing mice of both strains, significantly enhanced immune cell responsiveness to mitogenic stimulation. The addition of indomethacin (10 μg/ml) to cultures of spleen cells from these tumor‐bearing mice, as well as to DBA/1J mice bearing the Cloudman S‐91 melanoma, enhanced spleen‐cell responsiveness to mitogen‐induced DNA synthesis by as much as 156%. Indomethacin administration in vivo or in vitro had no significant effect on mitogen‐induced DNA synthesis of spleen cells from non‐tumor‐bearing animals. It is hypothesized that tumors, or tumor‐cell antigens, increase Pg production of a population of spleen cells, and that the increased Pg content of the spleen may be important in controlling immune responsiveness in mice.

AB - Spleen cells removed from C57Bl/6J mice bearing a methylcholanthrene‐induced fibrosarcoma (MC‐16) demonstrate suppressed responsiveness to phytohemagglutinin (PHA) and bacterial lipopolysaccharide (LPS) induced mitogenesis as compared to non‐tumorous mice. A similar depression of PHA‐induced mitogenesis was observed with spleen cells from C3H/HeJ mice bearing syngeneic mammary adenocarcinomas (C3HBA). The administration of indomethacin, a non‐competitive irreversible prostaglandin (Pg) synthesis inhibitor, (75 or 100 μg/mouse, IP) on an alternate day basis to groups of tumor‐bearing mice of both strains, significantly enhanced immune cell responsiveness to mitogenic stimulation. The addition of indomethacin (10 μg/ml) to cultures of spleen cells from these tumor‐bearing mice, as well as to DBA/1J mice bearing the Cloudman S‐91 melanoma, enhanced spleen‐cell responsiveness to mitogen‐induced DNA synthesis by as much as 156%. Indomethacin administration in vivo or in vitro had no significant effect on mitogen‐induced DNA synthesis of spleen cells from non‐tumor‐bearing animals. It is hypothesized that tumors, or tumor‐cell antigens, increase Pg production of a population of spleen cells, and that the increased Pg content of the spleen may be important in controlling immune responsiveness in mice.

UR - http://www.scopus.com/inward/record.url?scp=0017190503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017190503&partnerID=8YFLogxK

U2 - 10.1002/ijc.2910180514

DO - 10.1002/ijc.2910180514

M3 - Article

C2 - 186413

AN - SCOPUS:0017190503

VL - 18

SP - 653

EP - 660

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 5

ER -